Disease free survival | Overall survival | |||
---|---|---|---|---|
Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | |
Univariate | ||||
Gender | 1.005 (0.101-2.208) | NS | 1.298 (0.122-2.891) | NS |
Age | 1.091 (0.198-2.623) | NS | 1.255 (0.226-2.879) | NS |
Site of primary tumor | 0.698 (0.119-5.5196b) | NS | 0.869 (0.126-1.881) | NS |
Tumor size | 0.379 (0.103-0.743) | NS | 0.799 (0.136-1.606) | NS |
Depth of tumor invasion | 0.462 (0.102 -1.039) | NS | 0.729 (0.108 -1.692) | NS |
Lymph node metastasis | 3.232 (1.566-6.676) | 0.01 | 3.528 (1.6196b-7.869) | 0.008 |
TNM stage | 5.069 (1.981-12.620) | <0.001 | 5.869 (1.996-12.788) | <0.001 |
Histological grade | 3.982 (1.119-8.1196b) | 0.006 | 4.569 (1.126-10.281) | 0.001 |
miR-196a expression | 4.962 (1.663-10.612) | <0.001 | 4.996 (1.682-10.138) | <0.001 |
miR-196b expression | 4.903 (1.616-10.299) | <0.001 | 4.969 (1.618-10.210) | <0.001 |
miR-196a/miR-196b | 5.287 (1.970-12.396) | <0.001 | 5.899 (1.981-12.902) | <0.001 |
Multivariate | ||||
Lymph node metastasis | 2.162 (1.112-4.862) | 0.02 | 2.681 (1.193-5.628) | 0.01 |
TNM stage | 4.619 (1.882-10.206) | 0.001 | 4.689 (1.896-10.886) | 0.001 |
Histological grade | 2.682 (1.122-5.616) | 0.01 | 2.892 (1.128-5.918) | 0.01 |
miR-196a expression | 4.668 (1.632-10.261) | 0.001 | 4.691 (1.688-10.318) | 0.001 |
miR-196b expression | 4.532 (1.569-9.696) | 0.001 | 4.696 (1.618-10.110) | 0.001 |
miR-196a/miR-196b | 5.106 (1.920-10.638) | <0.001 | 5.292 (1.961-10.692) | <0.001 |